In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...
By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...
Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...
Before treatment, patients need a diagnosis confirmed ... which look for “biomarkers” of dementia, to be used for diagnosis in clinics in place of expensive scans. Meanwhile, trial results ...
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
The number of people diagnosed with dementia is skyrocketing worldwide. But treating even common health issues like high ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...